Secnidazole: Effective Single-Dose Treatment for Bacterial Vaginosis
Secnidazole
| Product dosage: 1 gr | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.75 | $55.00 (0%) | 🛒 Add to cart |
| 30 | $2.23 | $82.50 $67.00 (19%) | 🛒 Add to cart |
| 60 | $1.58 | $165.00 $95.00 (42%) | 🛒 Add to cart |
| 120 | $1.11
Best per pill | $330.00 $133.00 (60%) | 🛒 Add to cart |
Synonyms | |||
Secnidazole is a next-generation nitroimidazole antimicrobial agent specifically designed for the treatment of bacterial vaginosis in adult women. It offers a potent, targeted approach against anaerobic bacteria and protozoa, with a pharmacokinetic profile that supports single-dose oral administration. This medication represents a significant advancement in convenience and adherence over multi-day regimens, providing sustained therapeutic concentrations with minimal dosing frequency. Its structural properties enhance stability and reduce potential side effects commonly associated with older agents in its class.
Features
- Active ingredient: Secnidazole 2g
- Dosage form: Oral granules
- Administration: Single-dose regimen
- Mechanism: Nitroimidazole antimicrobial with selective toxicity against anaerobic pathogens
- Half-life: Approximately 17-29 hours
- Bioavailability: High oral absorption unaffected by food
Benefits
- Complete therapeutic course with just one dose
- High efficacy rates in clinical eradication of bacterial vaginosis
- Reduced risk of non-adherence compared to multi-day regimens
- Lower incidence of gastrointestinal disturbances than other nitroimidazoles
- Sustained therapeutic concentrations throughout treatment period
- Minimal impact on daily routine due to single administration
Common use
Secnidazole is primarily indicated for the treatment of bacterial vaginosis in adult women. It is also used off-label for certain protozoal infections including amebiasis, giardiasis, and trichomoniasis. The medication demonstrates particular utility in cases where patient compliance with multi-day antibiotic regimens is a concern, or when rapid therapeutic onset is desired. Clinical studies show effectiveness against Gardnerella vaginalis, Prevotella species, Mobiluncus species, and other anaerobic pathogens associated with bacterial vaginosis.
Dosage and direction
The standard dosage for bacterial vaginosis is a single 2g oral dose. The granules should be sprinkled onto applesauce, yogurt, or pudding and consumed immediately without chewing or crunching the granules. The mixture should not be stored for later use. Administration may occur with or without food, though taking with food may help minimize potential gastrointestinal discomfort. For other indications, dosage may vary based on practitioner assessment and infection severity.
Precautions
Patients should be advised to avoid alcohol consumption during treatment and for at least 72 hours after completion due to potential disulfiram-like reaction. Use with caution in patients with central nervous system diseases. Blood counts should be monitored during prolonged therapy. May cause dizziness or drowsiness; patients should exercise caution when operating machinery or driving. Not recommended during pregnancy unless clearly needed and benefits outweigh risks.
Contraindications
Hypersensitivity to secnidazole, other nitroimidazole derivatives, or any component of the formulation. Contraindicated in patients with history of blood dyscrasias. Should not be administered to patients taking disulfiram or within two weeks of disulfiram therapy. Not recommended for use during the first trimester of pregnancy.
Possible side effects
Common side effects (≥1%) include nausea, vomiting, diarrhea, abdominal pain, headache, and metallic taste. Less frequent adverse reactions (<1%) include dizziness, fatigue, constipation, dyspepsia, and decreased appetite. Rare cases of peripheral neuropathy, seizures, and leukopenia have been reported with prolonged high-dose therapy. Allergic reactions including rash and pruritus may occur.
Drug interaction
May potentiate effects of warfarin and other oral anticoagulants. Concurrent use with alcohol may cause disulfiram-like reaction. May increase serum levels of lithium and phenytoin. Drugs that induce hepatic enzymes (phenobarbital, rifampin) may decrease secnidazole concentrations. Cimetidine may prolong half-life. Use with caution with other neurotoxic drugs.
Missed dose
As secnidazole is administered as a single dose, missed dose protocol is generally not applicable. If vomiting occurs within 3 hours of administration, consult healthcare provider regarding potential re-dosing. Do not double dose.
Overdose
Symptoms may include nausea, vomiting, ataxia, and neurological symptoms. There is no specific antidote. Treatment should be symptomatic and supportive. Gastric lavage may be considered if presented soon after ingestion. Hemodialysis may be effective due to low molecular weight and moderate protein binding.
Storage
Store at controlled room temperature 20°-25°C (68°-77°F). Keep packet in original container until ready to use. Protect from moisture and light. Keep out of reach of children. Do not use after expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new medication. The prescribing physician should be aware of the patient’s complete medical history and current medications. Individual results may vary.
Reviews
Clinical trials demonstrate bacterial vaginosis cure rates of 70-85% at follow-up assessments. Patients report high satisfaction with single-dose convenience compared to traditional 7-day regimens. Healthcare providers note improved adherence rates and reduced treatment failure due to completed therapy. Some patients report mild gastrointestinal symptoms that typically resolve within 24-48 hours.